Publicaciones en colaboración con investigadores/as de University of Pittsburgh School of Medicine (18)

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. Antipsychotic drugs in first-episode psychosis: A target trial emulation in the FEP-CAUSAL Collaboration

    American Journal of Epidemiology, Vol. 193, Núm. 8, pp. 1081-1087

  3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

  4. Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis

    Brain Sciences, Vol. 14, Núm. 7

2022

  1. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 37-55

  2. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

  3. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  4. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism

    Nature Genetics, Vol. 54, Núm. 9, pp. 1320-1331

  5. Subtly altered topological asymmetry of brain structural covariance networks in autism spectrum disorder across 43 datasets from the ENIGMA consortium

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 2114-2125

  6. Virtual Ontogeny of Cortical Growth Preceding Mental Illness

    Biological Psychiatry, Vol. 92, Núm. 4, pp. 299-313

2021

  1. Author Correction: Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets (Nature Communications, (2019), 10, 1, (4958), 10.1038/s41467-019-13005-8)

    Nature Communications

  2. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4496-4510

2020

  1. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism

    Cell, Vol. 180, Núm. 3, pp. 568-584.e23

  2. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

    Nature Medicine, Vol. 26, Núm. 12, pp. 1912-1918

2019

  1. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407

2014

  1. Synaptic, transcriptional and chromatin genes disrupted in autism

    Nature, Vol. 515, Núm. 7526, pp. 209-215

2011

  1. Magnetoencephalography as a putative biomarker for Alzheimer's disease

    International Journal of Alzheimer's Disease

2009

  1. Substance use disorders and suicide attempts in bipolar subtypes

    Journal of Psychiatric Research, Vol. 43, Núm. 3, pp. 230-238